Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-α

Free Radical Biology and Medicine

Volumn 47, Issue 7, 2009, Pages 924-931

  Ramirez Tortosa, M Carmen ^a   Ramirez Tortosa, César L ^b   Mesa, M Dolores ^a   Granados, Sergio ^a   Gil, Ángel ^a   Quiles, José L ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Complejo Hospitalario de Jaén ^*  (Spain)

Author keywords

Cytochrome c oxidase; Cytochromes; Cytokines; High fat diet; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; AMINOTRANSFERASE; ANTIOXIDANT; CURCUMIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; HISTOPATHOLOGY; LIPID DIET; LIPID METABOLISM; MALE; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY CHAIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CURCUMIN; DIETARY FATS; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX IV; FATTY LIVER; LIVER; MALE; MITOCHONDRIA; OXIDATIVE STRESS; PHOSPHOLIPIDS; RABBITS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

ORYCTOLAGUS CUNICULUS;

EID: 69249228674     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.06.015     Document Type: Article

References (61)

1. Angulo P. Non-alcoholic fatty liver disease. N. Engl. J. Med. 346 (2002) 1221-1231
2. McCullough A.J. Pathophysiology of nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 40 (2006) S17-S19
3. Lieber C.S., Leo M.A.A., Mak K.M., Xu Y., Cao Q., Ren C., Ponomarenko A., and DeCarli L.M. Model of nonalcoholic steatohepatitis. Am. J. Clin. Nutr. 79 (2004) 502-509
4. Portincasa P., Grattagliano I., Palmieri V.O., and Palasciano G. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin. Biochem. 38 (2005) 203-217
5. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., Natale S., Vanni E., Villanova N., Melchionda N., and Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37 (2003) 917-923
6. Day C.P., and James O. Steatohepatitis: a tale of two "hits"?. Gastroenterology 114 (1998) 842-845
7. Aggarwal B.B., Sundaram C., Malani N., and Ichikawa H. Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 595 (2007) 1-75
8. Luper S. A review of plants used in the treatment of liver disease: part two. Altern. Med. Rev. 4 (1999) 178-188
9. Nanji A.A., Jokelainen K., Tipoe G.L., Rahemtulla A., Thomas P., and Dannengerg A.J. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-κB-dependent genes. Am. J. Physiol. Gastrointest. Liver. Physiol. 284 (2003) G321-G327
10. Mishra B., Priyadarsini K.I., Bhide M.K., Kadam R.M., and Mohan H. Reactions of superoxide radicals with curcumin: probable mechanisms by optical spectroscopy and EPR. Free Radic. Res. 38 (2004) 355-362
11. Wei Q.Y., Chen W.F., Zhou B., Yang L., and Liu Z.L. Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochim. Biophys. Acta 1760 (2006) 70-77
12. Priyadarsini K.I., Maity D.K., Naik G.H., Kumar M.S., Unnikrishnan M.K., Satav J.G., Satav J.G., and Mohan H. Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic. Biol. Med. 35 (2003) 475-484
13. Kai M., Eto T., Kondo K., Setoguchi Y., Higashi S., Maeda Y., and Setoguchi T. Synchronous circandian rhythms of mRNA levels and activities of cholesterol 7 alpha-hydroxylase in the rabbit and rat. J. Lipid Res. 36 (1995) 367-374
14. Ramírez-Tortosa M.C., Mesa M.D., Aguilera M.C., Quiles J.L., Baró L., Ramirez-Tortosa C.L., Martinez-Victoria E., and Gil A. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 147 (1999) 371-378
15. Quiles J.L., Mesa M.D., Ramírez-Tortosa C.L., Aguilera C.M., Battino M., Gil A., and Ramirez-Tortosa M.C. Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1225-1231
16. Sehayek E., Ono J.G., Shefer S., Nguyen L.B., Wang N., Batta A.K., Salen G., Smith J.D., Tall A.R., and Breslow J.L. Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc. Natl. Acad. Sci. USA 95 (1998) 10194-10199
17. Seifalian A.M., El-Desoky A., and Davidson B.R. Hepatic indocyanine green uptake and excretion in a rabbit model of steatosis. Eur. Surg. Res. 33 (2001) 193-201
18. Choe S.C., Kim H.S., Jeong T.S., Bok S.H., and Park Y.B. Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 38 (2001) 947-955
19. Quiles J.L., Ochoa J.J., Ramirez-Tortosa M.C., Huertas J.R., and Mataix J. Age-related mitochondrial DNA deletion in rat liver depends on dietary fat unsaturation. J. Gerontol. A Biol. Sci. Med. Sci. 61 (2006) 107-114
20. Lowry O.H., Rosebrough H.J., Farr A.L., and Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
21. LeBel C.P., Ischiropoulos H., and Bondy S.C. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5 (1992) 227-231
22. Quiles J.L., Martínez E., Ibáñez S., Ochoa J.J., Martín Y., López-Frías M., Huertas J.R., and Mataix J. Ageing-related tissue-specific alterations in mitochondrial composition and function are modulated by dietary fat type in the rat. J. Bioenerg. Biomembr. 34 (2002) 517-524
23. Battino M., Rugolo M., Romeo G., and Lenaz G. Kinetic alterations of cytochrome-c oxidase in cystic fibrosis. FEBS Lett. 199 (1986) 155-158
24. Agren J.J., Julkunen A., and Penttila I. Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column. J. Lipid Res. 33 (1992) 1871-1876
25. Lepage G., and Roy C.C. Direct transesterification of all classes of lipids in one-step reaction. J. Lipid Res. 27 (1986) 114-120
26. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., and Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94 (1999) 2467-2474
27. Otogawa K., Kinoshita K., Fujii H., Sakabe M., Shiga R., Nakatani K., Ikeda K., Nakajima Y., Ikura Y., Ueda M., Arakawa T., Hato F., and Kawada N. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis. Implications for the pathogenesis of human nonalcoholic steatohepatitis. Am. J. Pathol. 170 (2007) 967-980
28. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) Method. Methods 25 (2001) 402-408
29. Koteish A., and Mae Diehl A. Animal models of steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 16 (2002) 679-690
30. Zou Y., Li J., Lu C., Wang J., Ge J., Huang Y., Zhang L., and Wang Y. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 79 (2006) 1100-1107
31. Brunt E.M. Nonalcoholic steatohepatitis. Semin. Liver Dis. 24 (2004) 3-20
32. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., and Sanyal A.J. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
33. Tilg H., and Mae Diehl A. Citokines in alcohol and nonalcohol steatohepatitis. N. Engl. J. Med. 343 (2000) 1467-1476
34. Oneta C.M., and Dufour J.F. Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations. Swiss Med. Wkly. 132 (2002) 455-493
35. Lavine J.E. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J. Pediatr. 136 (2000) 734-738
36. Hasegawa T., Yoneda M., Nakamura K., Makino I., and Terano A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment. Pharmacol. Ther. 15 (2001) 1667-1672
37. Kugelmas M., Hill D.B., Vivian B., Marsano L., and McClain C.J. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 38 (2003) 413-419
38. Harrison S.A., Torgerson S., Hayashi P., Ward J., and Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 98 (2003) 2485-2490
39. Sanyal A.J., Mofrad P.S., Contos M.J., Sargeant C., Luketic V.A., Sterling R.K., Stravitz R.T., Shiffman M.L., Clore J., and Mills A.S. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin. Gastroenterol. Hepatol. 2 (2004) 1107-1115
40. Yakaryilmaz F., Guliter S., Savas B., Erdem O., Ersoy R., Erden E., Akyol G., Bozkaya H., and Ozenirler S. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study. Intern. Med. J. 37 (2007) 229-235
41. Bugianesi E., Gentilcore E., Manini R., Natale S., Vanni E., Villanova N., David E., Rizzetto M., and Marchesini G. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am. J. Gastroenterol. 100 (2005) 1082-1090
42. Nobili V., Manco M., Devito R., Ciampalini P., Piemonte F., and Marcellini M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 24 (2006) 1553-1561
43. Aguilera C.M., Ramírez-Tortosa C.L., Quiles J.L., Yago M.D., Martínez-Burgos M.A., Martínez-Victoria E., Gil A., and Ramírez-Tortosa M.C. Monounsaturated and n-3 but not n-6 polyunsaturated fatty acids improve hepatic fibrosis in hypercholesterolemic rabbits. Nutrition 21 (2005) 363-371
44. Uno M., Kurita S., Misu H., Ando H., Ota T., Matsuzawa-Nagata N., Kita Y., Nabemoto S., Akahori H., Zen Y., Nakanuma Y., Kaneko S., and Takamura T. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Hepatology 48 (2008) 109-118
45. Reyes-Gordillo K., Segovia J., Shibayama M., Tsutsumi M., Vergara P., Moreno M.G., and Muriel P. Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: role of TGF-b modulation and oxidative stress. Fundam. Clin. Pharmacol. 22 (2008) 417-427
46. Kaur G., Tirkey N., Bharrhan S., Chanana V., Rishi P., and Chopra K. Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents. Clin. Exp. Immunol. 145 (2006) 313-321
47. Buyssens N., Kockx M.M., Herman A.G., Lazou J.M., Van den Berg K., Wisse E., and Geerts A.A. Centrolobular liver fibrosis in the hypercholesterolemic rabbit. Hepatology 24 (1996) 939-946
48. Fan J.G., Zhong L., Tia L.Y., Xu Z.J., Li M.S., and Wang G.L. Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. World J. Gastroenterol. 11 (2005) 2346-2350
49. Laurent A., Nicco C., Tran Van Nhieu J., Borderie D., Chéreau C., Conti F., Jaffray P., Soubrane O., Calmus Y., Weill B., and Batteux F. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology 39 (2004) 1277-1285
50. Oliveira C.P., Gayotto L.C., Tatai C., Della Nina B.I., Lima E.S., Abdalla D.S., Lopasso F.P., Laurindo F.R., and Carrilho F.J. Vitamin C and vitamin E in prevention of nonalcoholic fatty liver disease (NAFLD) in choline deficient diet fed rats. Nutr. J. 7 (2003) 1-5
51. Quiles J.L., Huertas J.R., Mañas M., Battino M., and Mataix J. Physical exercise affects the lipid profile of mitochondrial membranes in rats fed with virgin olive oil or sunflower oil. Br. J. Nutr. 81 (1999) 21-24
52. Asai A., and Miyazawa T. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J. Nutr. 131 (2001) 2932-2935
53. Manjunatha H., and Srinivasan K. Hypolipidemic and antioxidant effects of dietary curcumin and capsaicin in induced hypercholesterolemic rats. Lipids 42 (2007) 1133-1142
54. Begriche K., Igoudjil A., Pessayre D., and Fromentry B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6 (2006) 1-28
55. Demeilliers C., Maisonneuve C., Grodet A., Mansouri A., Nguyen R., Tinel M., Lette'ron P., Degott C., Feldmann G., Pessayre D., and Fromenty B. Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology 123 (2002) 1278-1290
56. Pessayre D., Berson A., Fromenty B., and Mansouri A. Mitochondria in steatohepatitis. Semin. Liver Dis. 21 (2001) 57-69
57. Wakabayashi T. Megamitochondria formation. Physiology and pathology. J. Cell. Mol. Med. 6 (2002) 497-538
58. Kristal B.S., Park B.K., and Yu B.P. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 271 (1996) 6033-6038
59. Pérez-Carreras M., Del Hoyo P., Martín M.A., Rubio J.C., Martín A., Castellano G., Colina F., Arenas J., and Solis-Herruzo J.A. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38 (2003) 999-1007
60. Gulcubuk A., Altunatmaz K., Sonmez K., Haktanir-Yatkin D., Uzun H., Gurel A., and Aydin S. Effects of curcumin on tumour necrosis factor-a and interleukin-6 in the late phase of experimental acute pancreatitis. J. Vet. Med. A 53 (2006) 49-54
61. Leclercq I.A., Farrell G.C., Sempoux C., Peña A., and Horsmans Y. Curcumin inhibits NF-kB activation and reduces the severity of experimental steatohepatitis in mice. J. Hepatol. 41 (2004) 926-934